Ausgabe 3/2001
Inhalt (8 Artikel)
Economic Burden of Chronic Obstructive Pulmonary Disease
Mitchell Friedman, Daniel E. Hilleman
Cost Effectiveness of Emedastine versus Levocabastine in the Treatment of Allergic Conjunctivitis in 7 European Countries
Carlos Gouveia Pinto, Antoine Lafuma, Francis Fagnani, Mark J. C. Nuijten, Gilles Berdeaux
Cost of Treatment for Onychomycosis
David M. Stier, Curt Henke, Jeff Schein, Joe Doyle, Warren H. Schonfeld, Jeanette Broering
Cost-Benefit Analysis of Active Vaccination Campaigns Against Hepatitis A Among Daycare Centre Personnel in Israel
Gabriel Chodick, Yehuda Lerman, Tamar Peled, Hava Aloni, Shai Ashkenazi
Cost-Effectiveness Analysis of Inhaled Zanamivir in the Treatment of Influenza A and B in High-Risk Patients
Adrian D. Griffin, Andrew S. Perry, Douglas M. Fleming